000281534 001__ 281534
000281534 005__ 20251109002049.0
000281534 0247_ $$2doi$$a10.3389/fncel.2025.1572431
000281534 0247_ $$2pmid$$apmid:41030616
000281534 0247_ $$2pmc$$apmc:PMC12477191
000281534 0247_ $$2altmetric$$aaltmetric:182085757
000281534 037__ $$aDZNE-2025-01152
000281534 041__ $$aEnglish
000281534 082__ $$a610
000281534 1001_ $$aKunte, Sebastian T$$b0
000281534 245__ $$aDistinct reduction in relative microglial glucose uptake compared to astrocytes and neurons upon isolation from the brain environment.
000281534 260__ $$aLausanne$$bFrontiers Research Foundation$$c2025
000281534 3367_ $$2DRIVER$$aarticle
000281534 3367_ $$2DataCite$$aOutput Types/Journal article
000281534 3367_ $$0PUB:(DE-HGF)16$$2PUB:(DE-HGF)$$aJournal Article$$bjournal$$mjournal$$s1762159467_20022
000281534 3367_ $$2BibTeX$$aARTICLE
000281534 3367_ $$2ORCID$$aJOURNAL_ARTICLE
000281534 3367_ $$00$$2EndNote$$aJournal Article
000281534 520__ $$aMicroglial energy metabolism has gained attention for the treatment of neurodegenerative diseases. In vitro methods provide important insights; however, it remains unclear whether the metabolism of highly motile microglia is preserved outside their regular environment. Therefore, we directly compared the microglial glucose uptake in vivo and in vitro in mice.Microglia and astrocytes were isolated from the brain using immunomagnetic cell sorting following [18F]FDG injection in living mice, followed by gamma and single-cell radiotracing (scRadiotracing). Enriched cell fractions were incubated with excess [18F]FDG (50,000-fold) in vivo, washed, and measured equivalently. For all fractions, radioactivity per cell was normalized to the injected or incubated radioactivity, and ratios of microglialuptake were calculated relative to astrocytes and the microglia/astrocyte-negative fraction. The experiment was repeated using a glucose-free buffer and validated by in vitro incubation without prior in vivo [18F]FDG injection to exclude the influence of fasting and glucose injection.scRadiotracing results were compared against cell culture [18F]-FDG incubation. The in vivo glucose uptake of microglia was higher when compared to astrocytes (50.4-fold, p < 0.0001) and non-microglia/ non-astrocyte cells (10.6-fold, p < 0.0001). Microglia still exhibited the highest glucose uptake in vitro, but with a distinct reduction in microglia-to-astrocyte (5.7-fold, p < 0.0015) and microglia-to-microglia/astrocyte-negative ratios (1.7 fold, p < 0.0001). Fasting and in vitro incubation were used to validate the results. Cell culture indicated low microglial uptake compared to that in neurons (1:100) or astrocytes (1:10).Compared to astrocytes and other cells, microglia show a distinct reduction in uptake in vitro compared to in vivo uptake. Our results emphasize that in vitro experiments should be interpreted with caution when studying microglial energy metabolism.
000281534 536__ $$0G:(DE-HGF)POF4-352$$a352 - Disease Mechanisms (POF4-352)$$cPOF4-352$$fPOF IV$$x0
000281534 588__ $$aDataset connected to CrossRef, PubMed, , Journals: pub.dzne.de
000281534 650_7 $$2Other$$aglucose uptake
000281534 650_7 $$2Other$$ain vitro
000281534 650_7 $$2Other$$ain vivo
000281534 650_7 $$2Other$$amicroglia
000281534 650_7 $$2Other$$ascRadiotracing
000281534 7001_ $$0P:(DE-2719)9001652$$aGnoerich, Johannes$$b1$$udzne
000281534 7001_ $$aBeumers, Philipp$$b2
000281534 7001_ $$aBartos, Laura M$$b3
000281534 7001_ $$aWagner, Stephan$$b4
000281534 7001_ $$0P:(DE-2719)9001653$$aWind, Karin$$b5$$udzne
000281534 7001_ $$aHolzgreve, Adrien$$b6
000281534 7001_ $$aPötter, Dennis$$b7
000281534 7001_ $$aWerner, Rudolf A$$b8
000281534 7001_ $$aZiegler, Sibylle$$b9
000281534 7001_ $$aAlbert, Nathalie L$$b10
000281534 7001_ $$aColombo, Alessio$$b11
000281534 7001_ $$0P:(DE-2719)2442036$$aTahirovic, Sabina$$b12$$udzne
000281534 7001_ $$0P:(DE-2719)9001539$$aBrendel, Matthias$$b13$$eLast author$$udzne
000281534 773__ $$0PERI:(DE-600)2452963-1$$a10.3389/fncel.2025.1572431$$gVol. 19, p. 1572431$$p1572431$$tFrontiers in cellular neuroscience$$v19$$x1662-5102$$y2025
000281534 8564_ $$uhttps://pub.dzne.de/record/281534/files/DZNE-2025-01152.pdf$$yOpenAccess
000281534 8564_ $$uhttps://pub.dzne.de/record/281534/files/DZNE-2025-01152.pdf?subformat=pdfa$$xpdfa$$yOpenAccess
000281534 909CO $$ooai:pub.dzne.de:281534$$pdnbdelivery$$pdriver$$pVDB$$popen_access$$popenaire
000281534 9101_ $$0I:(DE-HGF)0$$6P:(DE-2719)9001652$$aExternal Institute$$b1$$kExtern
000281534 9101_ $$0I:(DE-HGF)0$$6P:(DE-2719)9001653$$aExternal Institute$$b5$$kExtern
000281534 9101_ $$0I:(DE-588)1065079516$$6P:(DE-2719)2442036$$aDeutsches Zentrum für Neurodegenerative Erkrankungen$$b12$$kDZNE
000281534 9101_ $$0I:(DE-588)1065079516$$6P:(DE-2719)9001539$$aDeutsches Zentrum für Neurodegenerative Erkrankungen$$b13$$kDZNE
000281534 9131_ $$0G:(DE-HGF)POF4-352$$1G:(DE-HGF)POF4-350$$2G:(DE-HGF)POF4-300$$3G:(DE-HGF)POF4$$4G:(DE-HGF)POF$$aDE-HGF$$bGesundheit$$lNeurodegenerative Diseases$$vDisease Mechanisms$$x0
000281534 9141_ $$y2025
000281534 915__ $$0StatID:(DE-HGF)0200$$2StatID$$aDBCoverage$$bSCOPUS$$d2024-12-14
000281534 915__ $$0StatID:(DE-HGF)0160$$2StatID$$aDBCoverage$$bEssential Science Indicators$$d2024-12-14
000281534 915__ $$0StatID:(DE-HGF)1050$$2StatID$$aDBCoverage$$bBIOSIS Previews$$d2024-12-14
000281534 915__ $$0StatID:(DE-HGF)1190$$2StatID$$aDBCoverage$$bBiological Abstracts$$d2024-12-14
000281534 915__ $$0LIC:(DE-HGF)CCBY4$$2HGFVOC$$aCreative Commons Attribution CC BY 4.0
000281534 915__ $$0StatID:(DE-HGF)1040$$2StatID$$aDBCoverage$$bZoological Record$$d2024-12-14
000281534 915__ $$0StatID:(DE-HGF)0100$$2StatID$$aJCR$$bFRONT CELL NEUROSCI : 2022$$d2024-12-14
000281534 915__ $$0StatID:(DE-HGF)0501$$2StatID$$aDBCoverage$$bDOAJ Seal$$d2023-12-04T12:35:29Z
000281534 915__ $$0StatID:(DE-HGF)0500$$2StatID$$aDBCoverage$$bDOAJ$$d2023-12-04T12:35:29Z
000281534 915__ $$0StatID:(DE-HGF)0113$$2StatID$$aWoS$$bScience Citation Index Expanded$$d2024-12-14
000281534 915__ $$0StatID:(DE-HGF)0700$$2StatID$$aFees$$d2024-12-14
000281534 915__ $$0StatID:(DE-HGF)0150$$2StatID$$aDBCoverage$$bWeb of Science Core Collection$$d2024-12-14
000281534 915__ $$0StatID:(DE-HGF)0510$$2StatID$$aOpenAccess
000281534 915__ $$0StatID:(DE-HGF)0030$$2StatID$$aPeer Review$$bDOAJ : Anonymous peer review$$d2023-12-04T12:35:29Z
000281534 915__ $$0StatID:(DE-HGF)0561$$2StatID$$aArticle Processing Charges$$d2024-12-14
000281534 915__ $$0StatID:(DE-HGF)9905$$2StatID$$aIF >= 5$$bFRONT CELL NEUROSCI : 2022$$d2024-12-14
000281534 915__ $$0StatID:(DE-HGF)0300$$2StatID$$aDBCoverage$$bMedline$$d2024-12-14
000281534 915__ $$0StatID:(DE-HGF)0199$$2StatID$$aDBCoverage$$bClarivate Analytics Master Journal List$$d2024-12-14
000281534 9201_ $$0I:(DE-2719)1110007$$kAG Haass$$lMolecular Neurodegeneration$$x0
000281534 9201_ $$0I:(DE-2719)1140003$$kAG Tahirovic$$lJuvenile Neurodegeneration$$x1
000281534 980__ $$ajournal
000281534 980__ $$aVDB
000281534 980__ $$aUNRESTRICTED
000281534 980__ $$aI:(DE-2719)1110007
000281534 980__ $$aI:(DE-2719)1140003
000281534 9801_ $$aFullTexts